Categories: Journo Jobs

BioPharm Insight seeks investigative reporter

Come join our team at BioPharm Insight. Our New York newsroom is seeking a highly motivated reporter to join our dynamic investigative publication. The investigative Healthcare Reporter will focus on uncovering scoops and producing market moving pieces in advance of company announcements.

This challenging position will include covering all aspects of drug development, approval and marketing.

The successful candidate will keep a close eye on various aspects of the pharmaceutical and biotech sector, including R&D, licensing opportunities, M&A, regulatory issues, reimbursement, litigation and general industry trends.

QUALIFICATIONS

– Strong knowledge of the drug development process and healthcare industry

-Ability to perform to a high standard under pressure and meet strict deadlines

– Previous experience on a daily or weekly publication preferred

– Excellent communication, reporting, interviewing and writing skills

– Team-oriented approach with ability to work in an interactive news room environment

-Ability to collaborate on stories with our team of London reporters

– Bachelor’s degree (preferably in Journalism and/or science-related field)

ATTRIBUTES

– You are comfortable conducting interviews with high-level regulatory officials, physicians, consultants and industry executives.

-Your goal is to provide forward-looking reports on R&D activities.

-The pharmaceutical and biotech sectors, drug development regulations and reimbursement are topics you find fascinating.

– Uncovering new industry trends, facts and breaking news daily – your prime motivation.

– You keep on top of new developments.

– Health care and investor conferences are a place where you eagerly network and thrive.

BENEFITS AND COMPENSATION

The compensation package is competitive, with a benefits package of health, vision and dental insurance as well as a 401(k) plan. We offer a generous 20 days of paid time off (plus holidays as per the New York Stock Exchange).

ABOUT US

BioPharm Insight publishes real-time news and data on the most price-sensitive issues in the global healthcare market. Our diverse team consistently provides an exceptional product and level of analysis to a readership comprising: top-tier investment banks, hedge funds and corporate subscribers in the healthcare sector. BioPharm Insight is a part of Infinata, a division of the MergerMarket Group.

Interested candidates should send a cover letter, resume and two writing samples to Hanan Kamal, North American Editor, at hkamal@biopharminsight.com.

Chris Roush

Chris Roush was the dean of the School of Communications at Quinnipiac University in Hamden, Connecticut. He was previously Walter E. Hussman Sr. Distinguished Professor in business journalism at UNC-Chapel Hill. He is a former business journalist for Bloomberg News, Businessweek, The Atlanta Journal-Constitution, The Tampa Tribune and the Sarasota Herald-Tribune. He is the author of the leading business reporting textbook "Show me the Money: Writing Business and Economics Stories for Mass Communication" and "Thinking Things Over," a biography of former Wall Street Journal editor Vermont Royster.

Recent Posts

The Information hires Brown as senior finance editor

The Information has hired Ken Brown as senior finance editor. Brown was previously at the…

17 hours ago

Globe and Mail seeks a New York correspondent

The Globe and Mail is seeking a New York correspondent to report from the heart…

18 hours ago

Bloomberg Industry union: We want respect

The union that represents editorial staffers at Bloomberg Industry Group sent issued the following in…

19 hours ago

City AM is ending its Monday print edition

City AM, a publication covering London business news, has confirmed it is ending its Monday…

20 hours ago

Johnson says goodbye to WSJ colleagues

Kimberly Johnson, former election editor at The Wall Street Journal, wrote a goodbye email to…

20 hours ago

X hires former WSJ editor Stoll to lead partnerships

X has hired John Stoll, a former editor and Detroit bureau chief at The Wall…

23 hours ago